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Introduction
The Fontan procedure was developed as a means for separat-
ing the systemic and pulmonary circulation in patients with tri-
cuspid atresia, and was then applied to other patients with a
functionally single ventricle [1]. Venous hypertension is a
general feature of this circulation. A late complication devel-
ops in some patients, consisting of a substantial decrease of
serum protein and γ-globulin, an increase in stool α1-anti-
trypsin level, and a substantial loss of circulating lymphocytes
[2–5]. These features are typical of protein-losing enteropathy
(PLE), and are associated with significant mortality [4,6–8].
In the present report, we describe our observation of enteric
infection and inflammatory response at the onset of PLE in a
child with Fontan circulation. We have also reviewed the find-
ings in seven other patients with longstanding PLE.
185 EBV = Epstein–Barr virus; ELISA = enzyme-linked immunosorbent assay; IL = interleukin; PLE = protein-losing enteropathy.
Abstract
Introduction Protein-losing enteropathy (PLE) is a recognised complication of the Fontan circulation.
Its pathogenesis is not fully understood, however, and it is unclear why its onset occurs months or
even years after Fontan surgery.
Patients We report a 4.5-year-old girl with Fontan circulation who developed PLE almost 1 year after
surgery. At the time of onset the patient had rotavirus enteritis and streptococcal tonsillitis. We have
reviewed the records of seven other patients with longstanding PLE. In six of these patients we
identified infections at the onset of symptoms. None of our patients had evidence of opportunistic
infection.
Discussion and conclusion The immune system of patients with PLE is compromised, but reports on
recurrent opportunistic infections are rare. The present observations suggest that infection and
inflammation may be associated with the onset of PLE. The mechanism of how infection may trigger
PLE warrants further investigation.
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Patients and methods
The study was approved by the ethical committees of the
University of Leipzig (case 1) and  Munich (cases 2–8).
Written informed consent was obtained from the parents of
the patients. Since 1995, in Leipzig, we have formally fol-
lowed up children who have undergone the Fontan operation.
One child (case 1) out of 30 has developed PLE. We studied
seven other patients with PLE, who represented all post-
Fontan PLE survivors of the German Heart Centre Munich.
In each case, blood was taken to examine the haemoglobin,
the differential blood count, the haematocrit, and the serum
protein and globulin subset concentrations. IL-8 and anti-
Epstein–Barr virus (EBV) IgG concentrations were quantified
by ELISA (R&D Systems, Wiesbaden, Germany and IBL
GmbH, Hamburg, Germany, respectively). The concentration
of the complement fragment C3d was determined by radio-
immunodiffusion (The Binding Site, Heidelberg, Germany).
Surface antigen expression on neutrophils was determined by
flow cytometry from EDTA-anticoagulated blood [9] with the
antibodies anti-CD45, anti-CD11a and anti-CD11b (all anti-
bodies from BD-Biosciences, Heidelberg, Germany).
Results
Case 1
A girl with situs inversus, a double outlet right ventricle, pul-
monary atresia and D-transposition of the great arteries who
had previously undergone cardiac surgery at the age of
3 months (Blalock–Taussig shunt) and at the age of 3 years
(bidirectional Glenn anastomosis) underwent a Fontan-type
operation (total cavopulmonary connection, with intra-atrial
tunnel) at the age of 4.5 years. She was discharged 14 days
Figure 1
Time course of selected laboratory data. (a) Time course of the serum protein (solid line, filled circles; left scale) and the serum albumin level
(dotted lines, white circles; right scale), and (b) of the complement fragment C3d level (solid line, filled circles; left scale) and the C-reactive protein
(CRP) level (dotted lines, white circles; right scale) before, during and after the onset of protein-losing enteropathy (PLE). The vertical hatched line
shows the time range of PLE onset. Data are plotted versus time before/after the Fontan procedure.
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after surgery, prescribed digitoxin, spironolactone, frusemide,
acetylsalicylic acid and alprazolam. Six months later the
patient’s serum protein and albumin levels were within normal
limits (Fig.1a). The laboratory findings are summarised in
Table 1 (time range A, before PLE onset).
Eight months later, the patient was admitted to hospital with
rotavirus and streptococcal tonsillitis. She subsequently
developed oedema, and low serum protein (Fig.1a) and
γ-globulin concentrations. The patient also had an elevated
α1-antitrypsin level in the stool. The leukocyte count was
normal but the neutrophils were left-shifted. There was no
proteinuria. The laboratory findings at this time are sum-
marised in Table 1 (time range B). The patient recovered and
was discharged after 4 weeks.
Three weeks later (i.e. ~10 months after the total cavopul-
monary connection procedure), the patient was referred to our
Cardiac Centre because she had suspected infection, again
accompanied by oedema and markedly reduced exercise tol-
erance. On admission the patient was febrile and had oedema
of the legs, arms and face. The protein level was very low, and
the C-reactive protein concentration (normal value <1mg/l)
(Fig.1b) and the neutrophil count (normal range, see Table 1)
were increased. Serum albumin (Fig.1a), γ-globulin and IgG
concentration (Fig.2b) was decreased. Although the serum
anti-EBV IgG level (Fig.2b) was increased twofold to three-
fold, the IgA and IgM concentration was normal. The lympho-
cyte count was decreased (Table 1). The serum concentration
of IL-8 was increased (52.5pg/ml; normal range, <5pg/ml).
Finally, complement activation (Fig.1b), and CD45 (Fig.2a),
Available online http://ccforum.com/content/7/2/185
Figure 2
Time course of selected immunological data. (a) Time course of the blood neutrophil count (solid black line, filled circles; left scale) and the CD45
expression on neutrophils (determined by flow cytometry and expressed as mean fluorescence intensity; dotted lines, white circles; right scale), and
(b) the IgG level (solid black line, black circles; left scale) and the anti-Epstein–Barr virus (EBV)–IgG level (dotted lines, white circles; right scale)
before, during and after the onset of protein-losing enteropathy (PLE). For further details, see the last two sentences of the legend to Fig.1.
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CD11a (LFA-1; data not shown) and CD11b (Mac-1; data not
shown) expression on neutrophils were elevated.
The patient was at this time treated with protein (human
albumin, 4×50ml 20%/day), a single immunglobulin infusion
(Sandoglobin®), C1-esterase-inhibitor (Berinert®) and pred-
nisolon (3×5mg/day per orally; during the early phase, in
addition, 10–20mg intravenously) for 5 days and with antibi-
otics (Cefotiam®) for 6 days. The serum albumin level nor-
malised while the protein level was still at the lower end of the
normal range and below pre-PLE levels (Fig.1a). The serum
concentration of C-reactive protein was not increased after
5 days of treatment. Endoscopy and gastric and intestinal
biopsies showed no signs of lymphangiectasia. Cardiac
catheterisation and angiography revealed minimal stenosis of
the right pulmonary artery (pressure gradient, 2mmHg). Sys-
temic venous and right atrial pressure were moderately
increased (mean, 11mmHg).
The patient was followed up for the next 5 months and contin-
ued on prednisolone (5mg/day), alprazolam, diuretics
(furosemide and spironolacton), digitoxin and acetylsalicylic
acid. The serum protein, albumin, IgG and γ-globulin levels
remained below pre-PLE levels while the neutrophil count,
CD45 expression on neutrophils, complement activation and
anti-EBV–IgG remained increased (Figs1 and2). The lym-
phocyte count decreased and, on average, was below pre-
PLE values (Table 1). Follow-up of the patient ended 480
days after surgery without resolution of PLE. The laboratory
findings until final discharge are summarised in Table 1 (time
range C). After the infections at the onset of PLE, no further
infections were diagnosed until the end of the followup.
Cases 2–8
The records and investigations of the seven other patients
with longstanding PLE were reviewed. The age (mean±SD)
at Fontan-type surgery was 5.5±0.8 years, and PLE devel-
oped 48±32 months after surgery. Six out of the seven
patients (i.e. not case 3) had an infection at the time of onset
of PLE. Lymphangiectasia was not excluded in any of these
cases. The stool α1-antitrypsin level was determined only in
cases 5 and 7, and was increased at this time. Protein levels
were below the normal range at PLE onset; α1-globulin,
α2-globulin and β-globulin were elevated in most patients,
whereas  γ-globulin was below the normal range only in
case 3 (Table 1, time range B). The leukocyte count was
normal in all patients. The lymphocyte count was determined
in four patients and was below the normal range in three of
them. C-reactive protein was analysed only in case 3, and
was 47mg/dl.
Cases 2–4, 6 and 7 had a decreased lymphocyte count, ele-
vated  α1-globulin,  α2-globulin and β-globulin in the serum,
and elevated α1-antitrypsin in the stool during longstanding
PLE. The γ-globulin level remained in the normal range. Com-
plement fragment C3d was 6.9±2.1g/l (normal range
Available online http://ccforum.com/content/7/2/185
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2–4 g/l) and IL-8 was 11.1±6.6pg/ml, both values were only
slightly increased. Case 5 had normal values (C3d, 2.2g/l;
IL-8, 5.3pg/ml). Case 4 had recurrent infections with
rotavirus, but no subsequent infections were reported in the
other six patients.
Discussion
The principal observation in the present report is that,
between 230 and 270 days after the total cavopulmonary
connection procedure, in a child with congenital heart
disease, we found the development of PLE to be associated
with (enteric) infection and an acute inflammatory response.
Since we failed to identify any reports about the immunologi-
cal findings in the early phase of PLE, we reviewed seven
other patients with longstanding PLE. In all but one of these
patients, infection was associated with the onset of PLE after
Fontan surgery.
It is possible that the association between infection and PLE
might be a symptom of an impaired immune system during
the early development of PLE, rather than a causal factor.
However, reports of opportunistic infections in patients with
PLE are rare [5,10]. This finding is in agreement with our
observation that only one of our patients had recurrent infec-
tions. In fact, the present data from case 1 indicate that
B lymphocytes are still capable of producing specific antibod-
ies (such as anti-EBV IgG).
As with many retrospective studies, the present study does
have limitations. It would have been useful to have undertaken
cell function assays and more detailed bacteriological and
virological laboratory analysis. We cannot exclude the possi-
bility that infection at PLE onset is a mere coincidence, albeit
present in the majority (seven of eight patients; 95% confi-
dence interval, 47–99%). Also, although lymphangiectasia
was not found it could have been present in other areas and
might have been missed on the biopsies, as proposed by
others [3].
Finally, is an ‘infection hypothesis’ plausible for the develop-
ment of PLE in Fontan patients? We speculate that it is. All
patients with a Fontan circulation exhibit an elevated central
venous pressure and an elevated resistance to gut perfusion
[4,8]. The thyroid stimulating hormone serum level is reduced,
for an extended time, after Fontan surgery [11]. Together,
these factors could contribute to an impairment of the enteric
immune defence system [12]. Increased pressure is pro-
inflammatory for the lung and other organs [13], and thyroid
stimulating hormone maintains the gastric mucosal immune
defence by intraepithelial lymphocytes [14]. A primed and
impaired immune system reacts more severely to stress. An
impairment of gastric mucosal defence could, in affected indi-
viduals, be more susceptible to various stressors. We hypoth-
esise that infection might serve as a trigger for PLE. Indeed,
the infections we identified around the time of onset of PLE
are not uncommon in children.
Conclusion
Our observation in postoperative patients with Fontan circula-
tion may indicate that infection could be an additional stimu-
lus for the development of PLE. Such a hypothesis could
explain why PLE occurs with varying intervals after surgery.
We suggest that further studies, with an extended number of
patients, are needed to understand the potential role of infec-
tion in the development of PLE.
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